Metraipolis › archive › dc_488dfdc14148

In Silico Design and Analysis of a Novel Ranibizumab-derived Peptide against the Vascular Endothelial Growth Factor — Europe PMC PMID:41726370

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41726370
DOI: 10.18502/jovr.v21.16222
License (as archived): solo-consultazione
Archived: 2026-11-05T19:08:20.258Z
SHA-256 of the archived text: acaa4b81a202b6f9f02a7b852fd63e4e95fcb7ee498eb0b8e3a7125b9e292bbf
Stable URL of this page: https://metraipolis.com/documento/dc_488dfdc14148

How to cite

In Silico Design and Analysis of a Novel Ranibizumab-derived Peptide against the Vascular Endothelial Growth Factor — Europe PMC PMID:41726370 — Europe PMC (en), https://europepmc.org/article/MED/41726370 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_488dfdc14148 (Metraipolis archive dc_488dfdc14148, sha256 acaa4b81a202b6f9f02a7b852fd63e4e95fcb7ee498eb0b8e3a7125b9e292bbf)

BibTeX

@misc{dc488dfdc14148,
  title = {In Silico Design and Analysis of a Novel Ranibizumab-derived Peptide against the Vascular Endothelial Growth Factor — Europe PMC PMID:41726370},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41726370},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_488dfdc14148; sha256 acaa4b81a202b6f9f02a7b852fd63e4e95fcb7ee498eb0b8e3a7125b9e292bbf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41726370. Agents can read the archived copy with the MCP tool read_document.